3051 - 3075 of 9104 Results
Title
Year
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 98
-
RESTRICTEDTitle: Altered resting‐state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 8Issue #: 9Start Page: e01073End Page: e01073Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.1073Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.1073Citation Count: 0
-
OPENTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page: e96End Page: e96Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 6
-
OPENTitle: Dream Content Predicts Motor and Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1041End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13318Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8485616Citation Count: 15
-
OPENTitle: Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 2Start Page: 254End Page: 263Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13143Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13143Citation Count: 18
-
OPENTitle: Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 718End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12997Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12997Citation Count: 8
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26923Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26923Citation Count: 22
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 307
-
RESTRICTEDTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: http://doi.org/10.1002/mds.26251Citation Count: 116
- Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years2024OPENTitle: Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 YearsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 6Start Page: 686End Page: 697Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14044Best OA location URL: https://research-information.bris.ac.uk/en/publications/882c3e53-2aa7-4b20-9e98-9fa553842eb3Citation Count: 21
- Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression2016OPENTitle: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1535End Page: 1542Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26754Citation Count: 150
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 140
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 13
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 85
- Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives2024OPENTitle: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to RelativesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 786End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14043Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14043Citation Count: 0
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 201
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 40
- Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease2021OPENTitle: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 490End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28886Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940677Citation Count: 22
-
OPENTitle: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 474End Page: 479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29306Citation Count: 21
-
OPENTitle: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®Journal Name: European RadiologyPublisher: Springer Science and Business Media LLCVol: 32Issue #: 5Start Page: 2949End Page: 2961Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00330-021-08385-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00330-021-08385-9.pdfCitation Count: 19
-
OPENTitle: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative studyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 6Start Page: 935End Page: 949Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/40503Citation Count: 224
-
OPENTitle: CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 5Start Page: 683End Page: 697Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1148-zBest OA location URL: http://doi.org/10.1007/s00401-013-1148-zCitation Count: 112
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 49
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 29